GALEZ Stock Overview
Operates as a healthcare service provider in Switzerland and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Galenica AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CHF 75.20 |
52 Week High | CHF 78.18 |
52 Week Low | CHF 65.20 |
Beta | 0.19 |
11 Month Change | 1.97% |
3 Month Change | 2.31% |
1 Year Change | 11.00% |
33 Year Change | 15.25% |
5 Year Change | n/a |
Change since IPO | 75.29% |
Recent News & Updates
Recent updates
Shareholder Returns
GALEZ | GB Healthcare | GB Market | |
---|---|---|---|
7D | 3.7% | -2.2% | 1.4% |
1Y | 11.0% | -14.0% | 8.1% |
Return vs Industry: GALEZ exceeded the UK Healthcare industry which returned -14% over the past year.
Return vs Market: GALEZ exceeded the UK Market which returned 8.1% over the past year.
Price Volatility
GALEZ volatility | |
---|---|
GALEZ Average Weekly Movement | 2.0% |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 9.5% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: GALEZ has not had significant price volatility in the past 3 months.
Volatility Over Time: GALEZ's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 7,955 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.
Galenica AG Fundamentals Summary
GALEZ fundamental statistics | |
---|---|
Market cap | CHF 3.75b |
Earnings (TTM) | CHF 169.68m |
Revenue (TTM) | CHF 3.80b |
22.1x
P/E Ratio1.0x
P/S RatioIs GALEZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GALEZ income statement (TTM) | |
---|---|
Revenue | CHF 3.80b |
Cost of Revenue | CHF 3.34b |
Gross Profit | CHF 464.58m |
Other Expenses | CHF 294.90m |
Earnings | CHF 169.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 11, 2025
Earnings per share (EPS) | 3.41 |
Gross Margin | 12.22% |
Net Profit Margin | 4.46% |
Debt/Equity Ratio | 42.9% |
How did GALEZ perform over the long term?
See historical performance and comparison